Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study-Reference-Cited by-同舟云学术

Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study

Published:2021-11-02 Issue:2 Volume:115 Page:208-221
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Hashimoto Yoshinori,Ito Tomoki,Gotoh Akihiko,Nakamae Mika,Kimura Fumihiko,Koike Michiaki,Kirito Keita,Wada Hideho,Usuki Kensuke,Tanaka Takayuki,Mori Takehiko,Wakita Satoshi,Saito Toshiki I.,Kada Akiko,Saito Akiko M.,Shimoda Kazuya,Sugimoto Yuka,Kurokawa Toshiro,Tomita Akihiro,Edahiro Yoko,Akashi Koichi,Matsumura Itaru,Takenaka Katsuto,Komatsu Norio^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12185-021-03253-0.pdf

Reference47 articles.

1. Tefferi A, Pardanani A. Essential thrombocythemia. N Engl J Med. 2019;381:2135–44.

2. Moulard O, Mehta J, Fryzek J, Olivares R, Iqubal U, Mesa RA. Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union. Eur J Haematol. 2014;92:289–97.

3. Titmarsh GJ, Duncombe AS, McMullin MF, O’Rorke M, Mesa R, De Vocht F, et al. How common are myeloproliferative neoplasms? A systematic review and meta-analysis. Am J Hematol. 2014;89:581–7.

4. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352:1779–90.

5. Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M, et al. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med. 2006;3:e270.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis;Annals of Hematology;2024-07-22

2. Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms;World Journal of Clinical Oncology;2024-06-24

3. Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan;Hematology;2024-04-16

4. Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based study;British Journal of Haematology;2024-02-13

5. Presence and Onset of Chronic Kidney Disease as a Factor Involved in the Poor Prognosis of Patients with Essential Thrombocythemia;Advances in Hematology;2024-01